SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-028483
Filing Date
2018-05-15
Accepted
2018-05-15 10:01:19
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv493209_10q.htm 10-Q 281067
2 EXHIBIT 31.1 tv493209_ex31-1.htm EX-31.1 8532
3 EXHIBIT 31.2 tv493209_ex31-2.htm EX-31.2 7886
4 EXHIBIT 32.1 tv493209_ex32-1.htm EX-32.1 4457
5 EXHIBIT 32.2 tv493209_ex32-2.htm EX-32.2 4346
  Complete submission text file 0001144204-18-028483.txt   2504697

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT casi-20180331.xml EX-101.INS 357364
7 XBRL TAXONOMY EXTENSION SCHEMA casi-20180331.xsd EX-101.SCH 37802
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20180331_cal.xml EX-101.CAL 26768
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20180331_def.xml EX-101.DEF 219647
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20180331_lab.xml EX-101.LAB 259579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20180331_pre.xml EX-101.PRE 253361
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 18833770
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1